2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
34
Leiomyoma
12
Menorrhagia
5
Endometriosis
4
Myofibroma
3
Prostate Adenocarcinoma
2
Pregnancy Complications
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Pathologic Complete Response
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myoma
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-Resistant Prostate Cancer
1
Hormone Treatment-naïve Participants With Prostate Cancer
1
Interventions
Androgen Antagonists
3
darolutamide
2
Docetaxel
2
relugolix
1
niraparib
1
Prednisone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
relugolix
×
Clear all
NCT07216248
2025-10-29
OPTIMAS
University of Utah
Phase 2
Recruiting
160 enrolled